The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumour DNA carrying patient-specific mutations in TP53 as an early response biomarker in relapsed high grade serous ovarian cancer.
 
Christine A. Parkinson
No Relationships to Disclose
 
Davina Gale
Employment - Inivata
Leadership - Inivata
Stock and Other Ownership Interests - GlaxoSmithKline; GlaxoSmithKline (I); Inivata
Patents, Royalties, Other Intellectual Property - Inivata
 
Anna Piskorz
No Relationships to Disclose
 
Charlotte Hodgkin
No Relationships to Disclose
 
Heather Biggs
No Relationships to Disclose
 
Helen Addley
No Relationships to Disclose
 
Penny Moyle
No Relationships to Disclose
 
Sue Freeman
No Relationships to Disclose
 
Evis Sala
No Relationships to Disclose
 
Karen Hosking
No Relationships to Disclose
 
Ioannis Gounaris
Honoraria - PharmaMar
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Mercedes Jimenez-Linan
No Relationships to Disclose
 
Helena Margaret Earl
Consulting or Advisory Role - AstraZeneca; Celgene; Pfizer; Roche
Research Funding - PharmaMar (Inst); Roche (Inst); Sanofi (Inst)
 
Wendi Qian
No Relationships to Disclose
 
Nitzan Rosenfeld
Leadership - Inivata
Stock and Other Ownership Interests - Inivata
Consulting or Advisory Role - Inivata
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - Inivata
 
James D. Brenton
Stock and Other Ownership Interests - Inivata
Consulting or Advisory Role - Inivata
Speakers' Bureau - AstraZeneca
Patents, Royalties, Other Intellectual Property - TAm-Seq v2 method for ctDNA estimation
Travel, Accommodations, Expenses - Aprea AB; Clovis Oncology